...
首页> 外文期刊>Biochimica et biophysica acta. Molecular cell research >Tank Binding Kinase 1 modulates spindle assembly checkpoint components to regulate mitosis in breast and lung cancer cells
【24h】

Tank Binding Kinase 1 modulates spindle assembly checkpoint components to regulate mitosis in breast and lung cancer cells

机译:罐结合激酶1调节主轴组件检查点组分以调节乳腺癌和肺癌细胞的有丝分裂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Error-free progression through mitosis is critical for proper cell division and accurate distribution of the genetic material. The anaphase-promoting complex/cyclosome (APC/C) ubiquitin ligase regulates the progression from metaphase to anaphase and its activation is controlled by the cofactors Cdc20 and Cdh1. Additionally, genome stability is maintained by the spindle assembly checkpoint (SAC), which monitors proper attachment of chromosomes to spindle microtubules prior to cell division. We had shown a role for Tank Binding Kinase 1 (TBK1) in microtubule dynamics and mitosis and here we describe a novel role of TBK1 in regulating SAC in breast and lung cancer cells. TBK1 interacts with and phosphorylates Cdc20 and Cdh1 and depletion of TBK1 elevates SAC components. TBK1 inhibition increases the association of Cdc20 with APC/C and BubR1 indicating inactivation of APC/C; similarly, interaction of Cdh1 with APC/C is also enhanced. TBK1 and TTK inhibition reduces cell viability and enhances centrosome amplification and micronucleation. These results indicate that alterations in TBK1 will impede mitotic progression and combining TBK1 inhibitors with other regulators of mitosis might be effective in eliminating cancer cells.
机译:通过有丝分裂的无差错进展对于适当的细胞分裂和准确分布的遗传物质至关重要。促进的泛素络合物(APC / C)泛素连接酶调节从中期中中期的进展,其活化由辅因子CDC20和CDH1控制。另外,基因组稳定性由主轴组件检查点(SAC)保持,其在细胞分裂之前监测染色体的适当附着到纺锤体微管。我们对微管动态和有丝分裂中的罐结合激酶1(TBK1)的作用显示了TBK1在乳腺癌和肺癌细胞中的CONCE调节囊中的一种新作用。 TBK1与CDC20和CDH1相互作用和磷酸化,TBK1的耗尽升高了囊组分。 TBK1抑制增加了CDC20与APC / C和BUBR1的关联,表明APC / C的失活;类似地,CDH1与APC / C的相互作用也得到增强。 TBK1和TTK抑制可降低细胞活力并增强中心体积扩增和微核。这些结果表明,TBK1中的改变将阻碍有丝分裂进展,并将TBK1抑制剂与其他有丝分裂调节剂的抑制剂组合可能有效地消除癌细胞。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号